- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoma, Bronchogenic in South Africa
Total 1817 results
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, China, Korea, Republic of, Denmark, Germany, Greece, Russian Federation, Hungary, France, New Zealand, Spain, Austria, Slovakia, United Kingdom, Malaysia, Lithuania, South Africa, Slovenia, Italy, Canada, Belgium, Poland, Czech Republic and more
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLung CancerFrance, Spain, Australia, United States, Sweden, Belgium, Switzerland, Italy, Egypt, South Africa, Israel, Colombia, Morocco, Norway, Greece, Brazil, Poland, Argentina, Austria, Chile, Czech Republic, Former Yugoslavia, Japan, Lithuania, Macedonia, The Former Yugoslav Republic... and more
-
Novartis PharmaceuticalsCompleted
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung CancerKorea, Republic of, Australia, Canada, United States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Australia, Japan, Korea, Republic of, Spain
-
SCRI Development Innovations, LLCBayerCompletedNon-Small Cell Lung CancerUnited States
-
Hoffmann-La RocheRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, France, Spain, Taiwan, United States, Israel, Australia, United Kingdom
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, Canada
-
BayerTerminatedSmall Cell Lung CarcinomaBelgium, United States, Korea, Republic of, Hungary, Poland, Japan, Germany, Italy, France
-
BioNTech SEActive, not recruitingSolid Tumor | Extensive-stage Small Cell Lung CancerUnited States, Spain, United Kingdom, Germany
-
National Cancer Institute (NCI)TerminatedLung CancerUnited States, South Africa
-
Eli Lilly and CompanyCompletedSmall Cell Lung CancerUnited States, China, Italy, Australia, Spain, Germany, Belgium, United Kingdom, Hungary, Taiwan, Austria, France, Poland, Greece, Netherlands, Brazil, India, Romania, Turkey, Russian Federation, Argentina, South Africa, Korea, Republic... and more
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
OSI PharmaceuticalsCompleted
-
CelgeneCompletedNon-Small Cell Lung CarcinomaUnited States, Canada
-
Merck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States, Ireland, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Peru, Poland, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
AmgenActive, not recruitingSmall Cell Lung CancerUnited States, Belgium, Austria, Singapore, Taiwan, Japan
-
SanofiGroupe Oncologie Radiotherapie Tete et CouCompletedHead and Neck Squamous Cell CarcinomaUnited States, France, Canada, Poland, Germany, Spain, Switzerland, Singapore, Taiwan, Argentina, Hungary, Italy, Chile, Hong Kong, South Africa, Australia, New Zealand
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungAustria, Germany, Spain, China, Taiwan, Argentina, Australia, Belgium, Brazil, Finland, France, Hungary, India, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Poland, Russian Federation, Ukraine, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedLung CancerAustralia, China, Romania, Colombia, Ireland, Israel, Japan, Spain, Peru, United States, Brazil, Greece, Singapore, Argentina, Austria, Belgium, Canada, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Mexico, Netherlands, ... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States, Australia, Peru, Puerto Rico
-
PeplinCompletedSuperficial Basal Cell CarcinomaAustralia
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
Impact Therapeutics, Inc.RecruitingSmall Cell Lung Cancer | Advanced Solid TumoursTaiwan, Korea, Republic of, China, Australia, United States
-
AbbottCompletedNon-Small Cell Lung CancerUnited States
-
GlaxoSmithKlineCompletedLung CancerUnited States, Canada, Puerto Rico
-
Bristol-Myers SquibbCompletedSmall Cell Lung CancerUnited States, Belgium, Canada, Puerto Rico, Australia, Korea, Republic of, Netherlands
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
Hoffmann-La RocheActive, not recruitingNon-Small-Cell LungUnited States, Korea, Republic of, United Kingdom, Australia, France, Italy, Spain, Japan, Brazil, China, Germany, Poland, Thailand, Israel, Switzerland, Taiwan, Austria, Russian Federation, Ukraine, Hungary, Serbia, Slovenia, South... and more
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSpain, Bulgaria, Serbia, United Kingdom, United States, Korea, Republic of, Malaysia, Vietnam, Poland, Egypt, Hungary, Ukraine, Brazil, Turkey, Japan, Portugal, Thailand, Philippines, Russian Federation, Italy, Mexico, Greece, Croatia, Chi... and more
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest... and other collaboratorsCompletedLung CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung CancerLung CancerUnited States
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Achieve Life SciencesCompletedNon-small Cell Lung CancerUnited States, Canada
-
Cancer Trials IrelandTerminatedColorectal Cancer | Non-Small Cell Lung CancerIreland
-
Cadex GenomicsCompletedMetastatic Colorectal Cancer | Metastatic Breast Cancer | Metastatic Non-Small Cell Lung CarcinomaUnited States, Canada
-
Medical University of South CarolinaTerminatedNewly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-IIUnited States
-
BeyondSpring Pharmaceuticals Inc.CompletedNon-Small Cell Lung CancerUnited States, China, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed